Franco Mantero

Active 1980–2019

92
Papers
24,997
Citations
82
h-index
92
i10-index

Citations

Citations per year for Franco Mantero1977: 2 citations1981: 2 citations1982: 1 citations1983: 7 citations1985: 5 citations1986: 7 citations1987: 8 citations1988: 3 citations1989: 1 citations1990: 1 citations1991: 7 citations1992: 12 citations1993: 14 citations1994: 5 citations1995: 6 citations1996: 11 citations1997: 18 citations1998: 13 citations1999: 21 citations2000: 19 citations2001: 21 citations2002: 27 citations2003: 47 citations2004: 71 citations2005: 90 citations2006: 85 citations2007: 134 citations2008: 154 citations2009: 165 citations2010: 112 citations2011: 130 citations2012: 169 citations2013: 137 citations2014: 130 citations2015: 213 citations2016: 181 citations2017: 188 citations2018: 174 citations2019: 769 citations2020: 813 citations2021: 596 citations2022: 439 citations2023: 290 citations2024: 452 citations2025: 251 citations2026: 16 citations1978–1980: no citations, so these years are not shown1984: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,259 citing papers, 19.4% of this breakdownItaly: 740 citing papers, 11.4% of this breakdownGermany: 499 citing papers, 7.7% of this breakdownUnited Kingdom: 454 citing papers, 7% of this breakdownFrance: 330 citing papers, 5.1% of this breakdownChina: 294 citing papers, 4.6% of this breakdownNetherlands: 261 citing papers, 4% of this breakdownAustralia: 228 citing papers, 3.5% of this breakdownCanada: 224 citing papers, 3.5% of this breakdownJapan: 213 citing papers, 3.3% of this breakdownSwitzerland: 156 citing papers, 2.4% of this breakdownSpain: 130 citing papers, 2% of this breakdown
0%19.4%Other 26.1%

Fields

  • Medicine85.1%
  • Biochemistry, Genetics and Molecular Biology9.1%
  • Neuroscience2.2%
  • Nursing1.1%
  • Computer Science0.7%
  • Pharmacology, Toxicology and Pharmaceutics0.3%
  • Other1.5%

Topics

  • Hormonal Regulation and Hypertension15.1%
  • Adrenal and Paraganglionic Tumors12.8%
  • Adrenal Hormones and Disorders9.5%
  • Pituitary Gland Disorders and Treatments7.7%
  • Renin-Angiotensin System Studies3.1%
  • Cancer, Hypoxia, and Metabolism2.5%
  • Other49.3%

Coauthors

All papers

Open in search
  1. The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline

    Authors: , , , , , , , - The Journal of Clinical Endocrinology & Metabolism 2016 cited by 2,881

  2. Outcomes after adrenalectomy for unilateral primary aldosteronism: an international consensus on outcome measures and analysis of remission rates in an international cohort

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Richard J. Auchus, Detlef K. Bartsch, René Baudrand, Felix Beuschlein, Peyman Björklund, Morris J. Brown, Jacopo Burrello, Robert M. Carey, Cristiana Catena, John Connell, Jaap Deinum, Tanja Dekkers, Thomas J. Fahey, Francesco Fallo, Carlos Fardella, Gilberta Giacchetti, Giuseppe Giraudo, Per Hellman, Andrzej Januszewicz, Kanako Kiriyama Kitamoto, Gregory Kline, Tomaž Kocjan, Jacques W.M. Lenders, Franco Mantero, Barbra S. Miller, Ryo Morimoto, Paolo Mulatero, Mitsuhide Naruse, Tetsuo Nishikawa, Uyen Thi Phuong Pham, Pierre‐François Plouin, Alexander Prejbisz, Marcus Quinkler, Marietta Rottenkolber, Christian L Rump, Fumitoshi Satoh, Leonardo A. Sechi, Michael Stowasser, Hironobu Umakoshi, Franco Veglio, J Widimský, Holger S. Willenberg, William F. Young - The Lancet Diabetes & Endocrinology 2017 cited by 945

  3. A Prospective Study of the Prevalence of Primary Aldosteronism in 1,125 Hypertensive Patients

    Authors: , , , , , , , , , , , , , , , , , , , , , , - Journal of the American College of Cardiology 2006 cited by 1,454

  4. Combination Chemotherapy in Advanced Adrenocortical Carcinoma

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Hanneke Wilmink, Monica Sender, Maureen Edgerly, W. Kenn, Tito Fojo, Hans‐Helge Müller, Britt Skogseid - New England Journal of Medicine 2012 cited by 864

  5. Integrated genomic characterization of adrenocortical carcinoma

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Felix Beuschlein, Rossella Libé, Aurélien de Reyniès, Jérôme Bertherat - Nature Genetics 2014 cited by 733

  6. Urine Steroid Metabolomics as a Biomarker Tool for Detecting Malignancy in Adrenal Tumors

    Authors: , , , , , , , , , , , , , , , , , , , , - The Journal of Clinical Endocrinology & Metabolism 2011 cited by 456

  7. Long-Term Control of Arterial Hypertension and Regression of Left Ventricular Hypertrophy With Treatment of Primary Aldosteronism

    Authors: , , , , , , , - Hypertension 2013 cited by 359

  8. Diagnosis and Complications of Cushing’s Syndrome: A Consensus Statement

    Authors: , , , , , , , , , , , , , , , , , , , - The Journal of Clinical Endocrinology & Metabolism 2003 cited by 1,365

  9. Adrenalectomy Lowers Incident Atrial Fibrillation in Primary Aldosteronism Patients at Long Term

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Carmine Zoccali - Hypertension 2018 cited by 190

  10. Somatic mutations in ATP1A1 and ATP2B3 lead to aldosterone-producing adenomas and secondary hypertension

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Nature Genetics 2013 cited by 568

  11. Genetic Spectrum and Clinical Correlates of Somatic Mutations in Aldosterone-Producing Adenoma

    Authors: , , , , , , , , , , , , , , , , , , , , , - Hypertension 2014 cited by 303

  12. A Survey on Adrenal Incidentaloma in Italy1

    Authors: , , , , , , , , - The Journal of Clinical Endocrinology & Metabolism 2000 cited by 268

  13. AME Position Statement on adrenal incidentaloma

    Authors: , , , , , , , , , , , , , , , , - European Journal of Endocrinology 2011 cited by 512

  14. Renal Damage in Primary Aldosteronism

    Authors: , , , , , , , , , , , , , , , - Hypertension 2006 cited by 458

  15. Placebo-controlled double-blind randomized trial on the use of l-carnitine, l-acetylcarnitine, or combined l-carnitine and l-acetylcarnitine in men with idiopathic asthenozoospermia

    Authors: , , , , , - Fertility and Sterility 2005 cited by 234

  16. Role of Nitric Oxide Concentrations on Human Sperm Motility

    Authors: , , , , , , , - Journal of Andrology 2004 cited by 151

  17. A Novel Mutation in the Upstream Open Reading Frame of the CDKN1B Gene Causes a MEN4 Phenotype

    Authors: , , , , , , , , , , , , , , , - PLoS Genetics 2013 cited by 150

  18. Adjuvant Mitotane Treatment for Adrenocortical Carcinoma

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2007 cited by 759

  19. High cardiovascular risk in patients with Cushing's syndrome according to 1999 WHO/ISH guidelines

    Authors: , , , , - Clinical Endocrinology 2004 cited by 279

  20. Aldosterone as a key mediator of the cardiometabolic syndrome in primary aldosteronism: an observational study

    Authors: , , , , , , - Journal of Hypertension 2006 cited by 193

  21. G-protein-coupled receptors in aldosterone-producing adenomas: a potential cause of hyperaldosteronism

    Authors: , , , , - Journal of Endocrinology 2007 cited by 114

  22. Diagnosis and complications of Cushing's disease: gender‐related differences

    Authors: , , , , , , , , , , , - Clinical Endocrinology 2013 cited by 92

  23. Genetic Landscape of Sporadic Unilateral Adrenocortical Adenomas Without PRKACA p.Leu206Arg Mutation

    Authors: , , , , , , , , , , , , , , , , , , , , , , - The Journal of Clinical Endocrinology & Metabolism 2016 cited by 89

  24. Comparison of the Captopril and the Saline Infusion Test for Excluding Aldosterone-Producing Adenoma

    Authors: , , , , , , , , , , , , , , , , - Hypertension 2007 cited by 156